| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 12/22/2004 | EP1488784A1 Male contraceptive implant |
| 12/22/2004 | EP1487992A2 Central airway administration for systemic delivery of therapeutics |
| 12/22/2004 | EP1487870A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 12/22/2004 | EP1487841A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors |
| 12/22/2004 | EP1487830A1 Novel crystalline form of 5-(4-((3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)methoxy)benzyl)thiazolidine-2,4-dione potassium salt |
| 12/22/2004 | EP1487822A2 Pyrrole-2,5-dione derivatives and their use as gsk-3 inhibitors |
| 12/22/2004 | EP1487805A1 Pyrimidine derivatives |
| 12/22/2004 | EP1487783A2 Irreversible selective androgen receptor modulators and methods of use thereof |
| 12/22/2004 | EP1487471A2 Methods for treating autoimmune disorders and reagents related thereto |
| 12/22/2004 | EP1487458A2 Multi-substitued selective androgen receptor modulators and methods of use thereof |
| 12/22/2004 | EP1487411A2 Inhalable sustained therapeutic formulations |
| 12/22/2004 | EP1333719A4 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 12/22/2004 | CN1556795A 3-desoxy-vitamin D3 analog esters |
| 12/22/2004 | CN1555814A Extracting method of propolis effective component and its use |
| 12/22/2004 | CN1181050C Noval substituted dimeric compounds, its preparing process and medicinal composition containing same |
| 12/22/2004 | CN1180842C Slow releasing microballoon injection of fish mature accelerating hormone and its prepn process |
| 12/22/2004 | CN1180801C Magnetotherapeutic medicinal pad and its preparing process |
| 12/21/2004 | US6833378 Pyridines, pyrimidines, purinones, pyrrolopyrimidinones and pyrrolopyridinones; useful in the treatment disorders including CNS and stress-related disorders. |
| 12/21/2004 | US6833372 A hormone inhibitors of gonadotropin releasing hormone, an antigonadotropins, new drug compound contains a furanyl 2-carboxylic acid -(2,4-dimethoxy-pyrimidin-5-yl)-amide groups |
| 12/16/2004 | WO2004075901A3 Compositon for increasing levels of hormones and a method for preparation of said composition |
| 12/16/2004 | WO2004064832A3 Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist |
| 12/16/2004 | US20040254382 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 12/16/2004 | US20040254378 2-Methanesulfone group; Side effect reduction; Nonsteroidal Antiinflammatory |
| 12/16/2004 | US20040254350 Immunomodulatory protein for use in diagnosis, treatment, and prevention of immune system, neurological, developmental, muscle and cell proliferative disorders |
| 12/16/2004 | US20040254249 Nonsteroidal antiinflammatory agents |
| 12/16/2004 | US20040254233 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 12/16/2004 | US20040254200 Antiinflammatory agents; controlling interleukins, tumor necrosis factor; antiarthritic agents; immunosuppressants |
| 12/16/2004 | US20040254192 2,4,5-trisubstituded thiazolyl derivatives and their antiinflammatory activity |
| 12/16/2004 | US20040254189 Jnk inhibitors |
| 12/16/2004 | US20040254176 Hypotensive agents; cardiovascular disorders; antidiabetic agents; skin disorders;kidney disorders; headaches; vision defects; strokes; synergistic mixture of amlodipine, benazepril and hydrochlorothiazide; oral administering |
| 12/16/2004 | US20040254144 Use of inhibitors of heparin-binding epidermal growth factor or inhibitors of its receptors for the preparation of drugs useful for treating myeloma |
| 12/16/2004 | US20040254122 increasing the tryptophan:large neutral amino acids ratio in blood by orally administering a rapidly digestible blend of no more than 40 g carbohydrate and a high tryptophan containing protein |
| 12/16/2004 | US20040254119 Polypeptide conjugates with extended circulating half-lives |
| 12/16/2004 | US20040254093 Antiinflammatory agents; cardiovascular disorders; anticancer agents; antidiabetic agents |
| 12/16/2004 | US20040253588 Cytochrome p450 monooxygenase for use in identifying modulators for treatment, diagnosis and prevention of autoimmune/inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, gastrointestinal and liver disorders |
| 12/16/2004 | US20040253326 Composition for increasing levels of hormones and a method for preparation of said composition |
| 12/16/2004 | US20040253301 Transdermal therapeutic system comprising a reservoir type pressure sensitive adhesive layer and a back layer with uni-directional resilience |
| 12/15/2004 | EP1485394A1 Process for isolation of eupalitin (3-o-beta-d-galactopyranoside) from boerhavia diffusa |
| 12/15/2004 | EP1485391A2 Phosphate transport inhibitors |
| 12/15/2004 | EP1485384A1 Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators |
| 12/15/2004 | EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 12/15/2004 | EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 12/15/2004 | EP1485356A1 NON-PEPTIDE GnRH ANTAGONISTS |
| 12/15/2004 | EP1485354A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 12/15/2004 | EP1485353A1 New inhibitors of histone deacetylase |
| 12/15/2004 | EP1485132A2 Combination of an aldosterone receptor antagonist and a fibric acid derivative |
| 12/15/2004 | EP1485105A1 Combination of an aldosterone receptor antagonist and a bile acid sequestering agent |
| 12/15/2004 | EP1485104A1 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative |
| 12/15/2004 | EP1485099A1 Inhibitors of histone deacetylase |
| 12/15/2004 | EP1485095A1 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 12/15/2004 | EP1485073A2 Method for administration of growth hormone via pulmonary delivery |
| 12/15/2004 | EP1485072A1 Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion. |
| 12/15/2004 | EP1485068A2 hGH (HUMAN GROWTH HORMONE) FORMULATIONS FOR PULMONARY ADMINISTRATION |
| 12/15/2004 | EP1485066A1 Composition having gelling properties for the prolonged delivery of bioactive substances |
| 12/15/2004 | EP1484966A2 Derivatives of isoflavones |
| 12/15/2004 | EP1453954A4 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof |
| 12/15/2004 | EP1399155A4 Small molecules useful in the treatment of inflammatory disease |
| 12/15/2004 | EP1322300B1 Inhalation particles incorporating a combination of two or more active ingredients |
| 12/15/2004 | EP1309594B1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 12/15/2004 | CN1555266A Hormone replacement therapy |
| 12/15/2004 | CN1554375A Method for producing Chinese medicine |
| 12/15/2004 | CN1554328A Microball preparation for intestine orient releasing medicne and its preparing method |
| 12/15/2004 | CN1179972C Growth hormone secretagogues |
| 12/15/2004 | CN1179961C Sulfonamides for treatment of endothelin-mediated disorders |
| 12/14/2004 | US6831199 Pyrimidine compounds and derivatives thereof |
| 12/14/2004 | US6831106 Vitamin D analogues |
| 12/14/2004 | US6831093 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof |
| 12/14/2004 | US6831059 Compositions and methods for treating gonadotrophin related illnesses |
| 12/09/2004 | WO2004106938A2 Diagnostics and therapeutics for diseases associated with g protein-coupled p2y purinoreceptor 7 (p2y7) |
| 12/09/2004 | WO2004106934A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) |
| 12/09/2004 | WO2004105768A1 Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases |
| 12/09/2004 | WO2003097082A3 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies |
| 12/09/2004 | WO2003053219A3 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 12/09/2004 | US20040249132 Nuclear hormone receptor ligand binding domain |
| 12/09/2004 | US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders |
| 12/09/2004 | US20040248923 Novel 4-anilinoquinoline-3-carboxamides |
| 12/09/2004 | US20040248921 Reducing androgen levels; acne, prostate diseases, alopecia, hirsutism; such as 17-chloromethylene-4-aza-5-alpha-estran-3-one |
| 12/09/2004 | US20040248867 Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives |
| 12/09/2004 | US20040248859 Medicinal compositions for treating secondary parathyroid hyperfunction and remedies for cardiovascular complications in association with treatment for secondary parathyroid hyperfunction |
| 12/09/2004 | US20040248278 Streptococcus expressing lymphocytic protein for use in prevention and treatment of insulin resistance, obesity, autism and attention deficit/hyperactivity disorders |
| 12/09/2004 | US20040248252 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 12/09/2004 | US20040248251 Receptors and membrane associated proteins |
| 12/09/2004 | US20040248188 Methods for using tetanus toxin for benificial purposes in animals (mammals) |
| 12/09/2004 | US20040248173 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder |
| 12/09/2004 | US20040247674 Drug delivery system |
| 12/09/2004 | CA2524750A1 Composition comprising progesterone-receptor antagonists and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases |
| 12/08/2004 | EP1483266A1 Spiro compounds with npy antagonistic activity |
| 12/08/2004 | EP1483242A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies |
| 12/08/2004 | EP1483239A2 Indole-amide derivatives and their use as glycogen phosphorylase inhibitors |
| 12/08/2004 | EP1483236A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 12/08/2004 | EP1482972A2 Treatment of immunological disorders using anti-cd30 antibodies |
| 12/08/2004 | EP1482967A1 Pharmaceutical and cosmetic compositions comprising plgf-1 |
| 12/08/2004 | EP1482962A2 Method of treating trx mediated diseases |
| 12/08/2004 | EP1482950A1 A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus |
| 12/08/2004 | EP1482949A1 Sulfatase inhibiting progestogen-only contraceptive regimens |
| 12/08/2004 | EP1482925A1 5-(2-hydroxy-3-'1-(3-trifluoromethylphenyl)-cyclopropl!-propionylamino)-phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replacement therapy |
| 12/08/2004 | EP1482896A2 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 12/08/2004 | EP1482895A2 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 12/08/2004 | EP1363898A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 12/08/2004 | EP1141014B1 Insulin-like growth factor (igf) i mutant variant |